An open-label phase IV study to evaluate whether a Medication Event Monitoring System (MEMS®) can improve adherence to Tecfidera® in MS
Clinical Trial Grant
Administered By
Neurology, MS & Neuroimmunology
Awarded By
Biogen Idec Inc.
Start Date
April 1, 2015
End Date
February 25, 2016
Administered By
Neurology, MS & Neuroimmunology
Awarded By
Biogen Idec Inc.
Start Date
April 1, 2015
End Date
February 25, 2016